IA2030 Scorecard

 — 

Global

  • Type to select a Country

SP 4: Life Course & Integration
4.1

Life-course vaccination

Breadth of protection (Mean Coverage across 12 antigens, %)—Global
Average (Mean) Coverage
3rd dose of diphtheria-tetanus-pertussis-containing vaccine (DTPcv3)
3rd dose of hepatitis B vaccine (HepB3)
3rd dose of Haemophilus influenzae type b vaccine (Hib3)
Final dose of human papillomavirus vaccine (HPV)
1st dose of inactivated poliovirus vaccine (IPV1)
1st dose of measles-containing vaccine (MCV1)
2nd dose of measles-containing vaccine (MCV2)
3rd dose of pneumococcal conjugate vaccine (PCV3)
3rd dose of polio vaccine (POL3)
1st dose of rubella-containing vaccine (RCV1)
Final dose of rotavirus vaccine series (ROTAC)

Summary Table

AntigenBaseline (2019)2021202220232024
Average (Mean) Coverage68%66%70%71%73%
3rd dose of diphtheria-tetanus-pertussis-containing vaccine (DTPcv3)86%81%85%84%85%
3rd dose of hepatitis B vaccine (HepB3)85%81%84%84%84%
3rd dose of Haemophilus influenzae type b vaccine (Hib3)74%72%77%77%78%
Final dose of human papillomavirus vaccine (HPV)12%12%14%21%28%
1st dose of inactivated poliovirus vaccine (IPV1)84%82%85%85%86%
1st dose of measles-containing vaccine (MCV1)86%81%83%83%84%
2nd dose of measles-containing vaccine (MCV2)71%70%73%73%76%
3rd dose of pneumococcal conjugate vaccine (PCV3)51%52%60%63%67%
3rd dose of polio vaccine (POL3)86%80%83%84%84%
1st dose of rubella-containing vaccine (RCV1)69%66%72%71%73%
Final dose of rotavirus vaccine series (ROTAC)40%49%52%55%59%

The metadata for this indicator can be viewed here. The metadata typically includes the indicator's definitions, method of estimation, limitations, and sources.